Description

According to a report by StrategyHelix, the global therapeutic biologics market is set to increase by US$ 169.7 billion during 2022-2028, growing at a CAGR of 7.7% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for therapeutic biologics. The global therapeutic biologics market is segmented on the basis of product, and region. On the basis of product, the global therapeutic biologics market has been segmented into therapeutic proteins, vaccines, others. Among these, the therapeutic proteins segment was accounted for the highest revenue generator in 2021. Geographically, the global therapeutic biologics market is segmented into Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America is estimated to account for the largest share of the global therapeutic biologics market.

The global therapeutic biologics market is highly competitive. Key companies profiled in the report include Amgen Inc., Baxter International Inc., China Biologic Products Holdings Inc., CSL Ltd., Eli Lilly and Company, GlaxoSmithKline plc (GSK plc), Grifols S.A., Kedrion S.p.A., Novartis AG, Octapharma AG, Reliance Life Sciences, Roche Holding AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the therapeutic biologics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: therapeutic proteins, vaccines, others
Region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global therapeutic biologics market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Therapeutic biologics market overview
Part 3. Market breakdown by product
– Therapeutic proteins
– Vaccines
– Others
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– MEA (Middle East and Africa)
– Latin America
Part 5. Key companies
– Amgen Inc.
– Baxter International Inc.
– China Biologic Products Holdings, Inc.
– CSL Ltd.
– Eli Lilly and Company
– GlaxoSmithKline plc (GSK plc)
– Grifols, S.A.
– Kedrion S.p.A.
– Novartis AG
– Octapharma AG
– Reliance Life Sciences
– Roche Holding AG
– Sanofi S.A.
– Teva Pharmaceutical Industries Ltd.
About StrategyHelix
Disclaimer